ClinicalTrials.Veeva

Menu
S

Southern California Medical Research Center | La Palma, CA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Clazakizumab
Ferric Citrate
RO7434656
KRX-0502

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 4 total trials

A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression (IMAGINATION)

The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics of sefaxersen (RO7434656), a novel Antisense Oligonucleotide (ASO...

Enrolling
Primary IgA Nephropathy
Drug: Placebo
Drug: Sefaxersen (RO7434656)

This is a 2-part (phase 2b/3) prospective, interventional, multicenter, randomized, double-blind, placebo-controlled study. Part 1 (phase 2b) is a do...

Enrolling
Atherosclerotic Cardiovascular Disease
Atherosclerotic Cardiovascular Disease in Patients With ESKD
Drug: Placebo
Drug: CSL300

Trial sponsors

Boehringer Ingelheim logo
CSL Behring logo
K
Roche logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems